Stryker Hip Lawsuit Plaintiffs Await Decisions on Mass Tort Petitions for LFIT V40 Femoral Head Claims, Bernstein Liebhard LLP Reports

NEW YORK, March 27, 2017 /PRNewswire/ -- Plaintiffs pursuing Stryker hip lawsuits involving LFIT Anatomic CoCr V40 Femoral Heads are awaiting decisions on two petitions that seek to centralize their claims in mass tort programs. On Thursday, March 30^th, the U.S. Judicial Panel on Multidistrict Litigation will hear Oral Arguments on a motion requesting the transfer of all such federal claims in a single U.S. District Court for the purposes of coordinated pretrial proceedings.  At least six cases involving the Stryker LFIT V40 component were pending in three federal courts when plaintiffs filed their Motion for Transfer in January. However, they contend that the litigation could eventually grow to include hundreds of similar claims. (In RE: Stryker Orthopaedics LFIT V40 Femoral Head Product Liability Litigation, MDL No. 2768)

Plaintiff pursuing Stryker LFIT V40 femoral head lawsuits in the state of New Jersey have also requested that their claims be consolidated in a multicounty litigation to be established in Bergen County Superior Court. According to their January 24^th petition, 85 cases involving LFIT V40 femoral heads were already pending in that jurisdiction. Comments on the proposal were to be submitted to the Acting Administrative Director of the Courts no later than March 6^th.

"Our Firm has heard from a number of individuals who suffered complications allegedly associated with taper lock failure of LFIT Anatomic CoCr V40 Femoral Heads. We believe that the litigation involving this Stryker hip component could be large, and would warrant the type of mass tort programs being considered," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free, no-obligation legal reviews to individuals who may have been harmed by Stryker's LFIT Anatomic Cobalt Chromium V40 femoral heads.

Stryker LFIT V40 Femoral Head Recall

Stryker issued an "Urgent Medical Device Recall Notification" to surgeons in August2016, warning that certain LFIT V40 Femoral Heads had been associated with  a higher-than-expected number of complaints involving taper lock failure.  Patients fitted with the affected components are at risk for:

• Loss of mobility
• Pain
• Inflammation
• Adverse local tissue reaction
• Dislocation
• Joint instability
• Bone fractures around the components
• Leg length discrepancy
• Need for revision surgery

The U.S. Food & Drug Administration (FDA) designated Stryker's notification a Class II recall in November 2016. Class II recalls involve medical devices that may cause temporary or medically reversible adverse health consequences.

Stryker's LFIT Anatomic Cobalt Chromium V40 femoral heads are used in combination with a number of the company's modular hip implants, including:

• Accolade TMZF
• Accolade 2 Stems
• Meridian Stems
• Citation Stems

Centralization of Stryker hip lawsuits involving LFIT V40 femoral heads would allow these cases to undergo coordinated discovery, motion practice, and other pretrial proceedings.  Mass tort programs, including multidistrict and multicounty litigations, are intended to improve judicial efficiency by preventing duplicative discovery and inconsistent court rulings. Consolidation would also help to preserve the resources of the courts, parties and witnesses involved in the litigation.

Compensation may be available to individuals who allegedly suffered pain, disability, and other complications resulting from the taper lock failure of a Stryker LFIT Anatomic CoCr V40 Femoral Head. To learn more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.rxinjuryhelp.com/
https://plus.google.com/115936073311125306742?rel=author

SOURCE Bernstein Liebhard LLP

Related Links

http://www.bernlieb.com